ReP USP - Resultado da busca

Artigo de periodico
Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension (2012)
Fontana, Vanessa; Silva, Pamela S.; Izidoro-Toledo, Tatiane C.; Biagi, Celso; Oliveira, Eduardo Brandt de; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Cardiovascular Drugs and Therapy. Unidades: FMRP, FORP
Subjects: ANGIOTENSINAS, METALOPROTEINASES, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTANA, Vanessa et al. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, v. 26, n. 6, p. 511-519, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10557-012-6420-2. Acesso em: 03 out. 2024.
APA
Fontana, V., Silva, P. S., Izidoro-Toledo, T. C., Biagi, C., Oliveira, E. B. de, Gerlach, R. F., & Tanus-Santos, J. E. (2012). Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, 26( 6), 511-519. doi:10.1007/s10557-012-6420-2
NLM
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s10557-012-6420-2
Vancouver
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s10557-012-6420-2
Artigo de periodico
Circulating matrix metalloproteinases and their inhibitors in hypertension (2012)
Fontana, Vanessa; Silva, Pamela S.; Gerlach, Raquel Fernanda; Santos, José Eduardo Tanus dos
Source: Clinica Chimica Acta. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO (ENZIMOLOGIA), METALOPROTEINASES, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTANA, Vanessa et al. Circulating matrix metalloproteinases and their inhibitors in hypertension. Clinica Chimica Acta, v. 413, n. 7-8, p. 656-662, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2011.12.021. Acesso em: 03 out. 2024.
APA
Fontana, V., Silva, P. S., Gerlach, R. F., & Santos, J. E. T. dos. (2012). Circulating matrix metalloproteinases and their inhibitors in hypertension. Clinica Chimica Acta, 413( 7-8), 656-662. doi:10.1016/j.cca.2011.12.021
NLM
Fontana V, Silva PS, Gerlach RF, Santos JET dos. Circulating matrix metalloproteinases and their inhibitors in hypertension [Internet]. Clinica Chimica Acta. 2012 ; 413( 7-8): 656-662.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.cca.2011.12.021
Vancouver
Fontana V, Silva PS, Gerlach RF, Santos JET dos. Circulating matrix metalloproteinases and their inhibitors in hypertension [Internet]. Clinica Chimica Acta. 2012 ; 413( 7-8): 656-662.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.cca.2011.12.021
Artigo de periodico
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism (2012)
Sousa-Santos, Ozelia; Neves, Evandro M. Neto; Ferraz, Karina C.; Ceron, Carla S.; Rizzi, Elen; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Naunyn-Schmiedeberg's Archives Pharmacology. Unidades: FORP, FMRP
Subjects: ANTIOXIDANTES, TROMBOEMBOLISMO, METALOPROTEINASES, TROPONINA I
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA-SANTOS, Ozelia et al. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism. Naunyn-Schmiedeberg's Archives Pharmacology, v. 385, n. 7, p. 685-696, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00210-012-0748-9. Acesso em: 03 out. 2024.
APA
Sousa-Santos, O., Neves, E. M. N., Ferraz, K. C., Ceron, C. S., Rizzi, E., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism. Naunyn-Schmiedeberg's Archives Pharmacology, 385( 7), 685-696. doi:10.1007/s00210-012-0748-9
NLM
Sousa-Santos O, Neves EMN, Ferraz KC, Ceron CS, Rizzi E, Gerlach RF, Tanus-Santos JE. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism [Internet]. Naunyn-Schmiedeberg's Archives Pharmacology. 2012 ; 385( 7): 685-696.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s00210-012-0748-9
Vancouver
Sousa-Santos O, Neves EMN, Ferraz KC, Ceron CS, Rizzi E, Gerlach RF, Tanus-Santos JE. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism [Internet]. Naunyn-Schmiedeberg's Archives Pharmacology. 2012 ; 385( 7): 685-696.[citado 2024 out. 03 ] Available from: https://doi.org/10.1007/s00210-012-0748-9

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em